MétaCan
Menu
Back to cohort
Record W4284663846 · doi:10.1007/s00270-022-03176-1

Dragon 1 Protocol Manuscript: Training, Accreditation, Implementation and Safety Evaluation of Portal and Hepatic Vein Embolization (PVE/HVE) to Accelerate Future Liver Remnant (FLR) Hypertrophy

2022· article· en· W4284663846 on OpenAlex
Remon Korenblik, Bram Olij, Luca Aldrighetti, Mohammad Abu Hilal, Margareta Ahle, Bülent Arslan, Laurens J. van Baardewijk, Ivan Baclija, Clare Bent, Claude Bertrand, Bergþór Björnsson, Marieke T. de Boer, Sanne de Boer, Reinoud P.H. Bokkers, Inne H.M. Borel Rinkes, Stefan Breitenstein, Rutger C. G. Bruijnen, Philipp Bruners, Markus W. Büchler, Juan C. Camacho, Alberta Cappelli, Ulrik Carling, B Chan, De‐Hua Chang, Jin‐Su Choi, J Codina Font, Michael Crawford, Daniel Croagh, Esteban Cugat, R Davis, D. W. De Boo, Francesco De Cobelli, J F De Wispelaere, Otto M. van Delden, Martin Delle, Olivier Detry, Rafael Díaz-Nieto, Alexandra Dili, Joris I. Erdmann, Oliver M. Fisher, Constantino Fondevila, Åsmund Avdem Fretland, F. García Borobia, Arantxa Gelabert, Laurent Gérard, Felice Giuliante, Paul D. Gobardhan, Fernando Gómez, Thomas Grünberger, Dirk J. Grünhagen, J. Guitart, Jeroen Hagendoorn, Jan Heil, Daniel Heise, Eduardo Ferrero Herrero, Gabriel Fridolin Hess, Michael Hoffmann, Roberto Iezzi, Farshad Imani, J Nguyen, Elio Jovine, Jörg C. Kalff, Geert Kazemier, T. Peter Kingham, Jörg Kleeff, Otto Kollmar, Wouter K. G. Leclercq, Valério Lucidi, Andrew Macdonald, David C. Madoff, Steffen Manekeller, Guillaume Martel, Arianeb Mehrabi, Homoyoon Mehrzad, Martijn R. Meijerink, Krishna Menon, Peter Metrakos, Christian P. Meyer, Adriaan Moelker, Sachin Modi, Nicola Montanari, Jordi Navinés, Ulf P. Neumann, Praveen Peddu, John Primrose, Xu-Dong Qu, Dimitri Aristotle Raptis, Francesca Ratti, Fourat Ridouani, Christopher Rogan, Ulrich Ronellenfitsch, Sara Ryan, Claudio Sallemi, J. Sampere Moragues, Per Sandström, L. Sarriá, Andreas A. Schnitzbauer, Matteo Serenari, Alejandro Serrablo, Mark Smits, Ernesto Sparrelid, Elmar Spüntrup, Gregor A. Stavrou, Robert P. Sutcliffe, I Tancredi, Jordan Tasse, Venkatesha Udupa, David Valenti, Y. Fundora, Thomas Vogl, Xu‐Wen Wang, Sharon White, W. A. Wohlgemuth, D Yu, IJ A J Zijlstra, Christoph A. Binkert, Marc H.A. Bemelmans, Christiaan van der Leij, Erik Schadde, Ronald M. van Dam

Why this work is in the frame

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

affAt least one author lists a Canadian institution in the pinned OpenAlex snapshot.

Bibliographic record

VenueCardioVascular and Interventional Radiology · 2022
Typearticle
Languageen
FieldMedicine
TopicHepatocellular Carcinoma Treatment and Prognosis
Canadian institutionsMcGill University Health CentreOttawa Hospital
FundersNational Center for Advancing Translational SciencesKWF KankerbestrijdingNational Institute for Health and Care ResearchAbbott VascularUniversiteit MaastrichtGuerbetMaastricht Universitair Medisch CentrumNational Cancer InstituteRush University
KeywordsMedicineMuscle hypertrophyClinical endpointPortal vein embolizationRandomized controlled trialRadiologyMulticenter trialHepatectomySurgeryInternal medicineResectionMulticenter study

Abstract

fetched live from OpenAlex

STUDY PURPOSE: The DRAGON 1 trial aims to assess training, implementation, safety and feasibility of combined portal- and hepatic-vein embolization (PVE/HVE) to accelerate future liver remnant (FLR) hypertrophy in patients with borderline resectable colorectal cancer liver metastases. METHODS: The DRAGON 1 trial is a worldwide multicenter prospective single arm trial. The primary endpoint is a composite of the safety of PVE/HVE, 90-day mortality, and one year accrual monitoring of each participating center. Secondary endpoints include: feasibility of resection, the used PVE and HVE techniques, FLR-hypertrophy, liver function (subset of centers), overall survival, and disease-free survival. All complications after the PVE/HVE procedure are documented. Liver volumes will be measured at week 1 and if applicable at week 3 and 6 after PVE/HVE and follow-up visits will be held at 1, 3, 6, and 12 months after the resection. RESULTS: Not applicable. CONCLUSION: DRAGON 1 is a prospective trial to assess the safety and feasibility of PVE/HVE. Participating study centers will be trained, and procedures standardized using Work Instructions (WI) to prepare for the DRAGON 2 randomized controlled trial. Outcomes should reveal the accrual potential of centers, safety profile of combined PVE/HVE and the effect of FLR-hypertrophy induction by PVE/HVE in patients with CRLM and a small FLR. TRIAL REGISTRATION: Clinicaltrials.gov: NCT04272931 (February 17, 2020). Toestingonline.nl: NL71535.068.19 (September 20, 2019).

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.588
Threshold uncertainty score0.603

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.080
GPT teacher head0.312
Teacher spread0.231 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it